CD8A and neoplasm: Tumors from mice treated with CTLA4-TβRII trap displayed higher proportions of 1) tumor reactive CD8+ IFNγ+ T cells, 2) CD4+ and CD8+ central memory T cells, and 3) lower percentage of FOXP3+ Tregs compared to control mice.